Dehydrozingerone, a Curcumin Analog, as a Potential Anti-Prostate Cancer Inhibitor in Vitro and in Vivo

• Main Authors: Sariya Mapoung, Shugo Suzuki, Satoshi Fuji, Aya Naiki-Ito, Hiroyuki Kato, Supachai Yodkeeree, Natee Sakorn, Chitchamai Ovatlarnporn, Satoru Takahashi, Pornngarm Limtrakul
• Format: Journal
• Published: 2020
• Subjects: Biochemistry, Genetics and Molecular Biology; Chemistry; Pharmacology, Toxicology and Pharmaceutics
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086687135&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/70226
• Institution: Chiang Mai University

© 2020 MDPI AG. All rights reserved. Curcumin (Cur) exhibits biological activities that support its candidacy for cancer treatment. However, there are limitations to its pharmacological effects, such as poor solubility and bioavailability. Notably, the use of Cur analogs has potential for addressing...